baber/WOPTO huggingface dataset:
Patent DK-276583-A (DK)
Inventor: TIITOLA JUHA KUSTAA
IPC: B29C65/02
Filed: 1983-06-15
Abstract: An injection port for injecting fluid through a needle into the contents of a container. The port has a covering film securing a sterile pad of resealabie material to a base member having a portion pierceable by a needle. A tear strip is heat welded to the cover so as to form a removable tab comprised of a welded tear strip section, a welded cover section and an unwelded lap forming a grip for removing the tab. The tab is connected to an unwelded portion of the cover by a tear joint of substantially less tear strength than either the tab or the unwelded cover portion. The cover and the base member define a chamber for maintaining the sterility of the pad until the tab is removed to expose a sterile portion of the pad for insertion of the needle. The base member may be a container wall, a tube communicating with the container interior, a mounting film providing a modular port, or a protector fim preventing contact hetween the pad and the bag contents. The cover may have a pull tab for removal of the pad. The modular port may be held in position by a pressure sensitive adhesive. A method for making the port is described.
Patent DK-284080-A (DK)
Inventor: STIRLING I
IPC: A61K31/545
Filed: 1980-07-01
Abstract: The present invention provides the compounds of the formula (II):   <CHEM> and esters thereof, wherein R<1> is a hydrogen atom or a lower alkyl group and R<2> is a hydrogen atom or lower alkyl group; or R<1> and R<2> together may represent a bond or a group - (CH2)n- where n is an integer from 1 to 6. These compounds are ss-lactamase inhibitors and antibacterial agents. Their use is described as are processes for their preparation.
Patent DK-287980-A (DK)
Inventor: CASSINELLI G
IPC: C07H15/252
Filed: 1980-07-03
Abstract: Compounds which, in form of therapeutical compositions, exhibit antitumoral activity. 
<??>These compounds are of the general formula I 
<CHEM>
 wherein R1 represents a hydrogen atom or a hydroxy or methoxy group, R2 represents a hydrogen atom or a hydroxy group, and each of R3 and R4 independently represents a hydrogen atom or a methyl group, with the proviso that R3 and R4 do not simultaneously represent hydrogen atoms and the pharmaceutically acceptable addition salts thereof, a process for producing said compounds and therapeutical composition containing same.
Patent DK-303789-A (DK)
Inventor: KURIHARA YOSHIE
IPC: A23L27/12
Filed: 1989-06-20
Abstract: A protein curuculin obtained by extracting from fresh Curuculigo latifolia fruits or dried fruits thereof with an aqueous solution of a salt of a concentration of at least 0.01 M; a taste-modifier for a sour material comprising fresh Curuculigo latifolia fruits, dried fruits thereof or a curuculin-containing material obtained therefrom; a chewing gum composition comprising fresh Curuculigo latifolia fruits, dried fruits thereof or a curuculin-containing material obtained therefrom; and a mouth-wash composition comprising fresh Curuculigo latifolia fruits, dried fruits thereof or curuculin-containing material obtained therefrom are disclosed.
Patent DK-366182-A (DK)
Inventor: SCHMIDT MOGENS FALCK
IPC: B66F/
Filed: 1982-08-16
Abstract: A passenger hoist comprises a frame 1 in which one end of a lifting arm 2 is journalled rotatably around a vertical axis. The opposite, free end of the lifting arm carries a personnel basket 3. In order that the personnel basket be able to be carried downwards relative to the support carrying the frame 1, the personnel basket 3 is suspended in a hoisting winch 4 at one end of a carrying arm 5. The carrying arm is axially displaceable in a first bushing 6 which is connected to one side of an intermediate arm 7, and the intermediate arm is axially displaceable and rotatable in a second bushing 8 being connected to the free end of the lifting arm 2. Both bushings are such designed and connected to the arms that the intermediate arm 7 can be turned from a position in parallel with the lifting arm 2 and the carrying arm 5, respectively, to a position where the intermediate arm 7 is orthogonal to the lifting arm 2 and/or the carrying arm 5. <IMAGE>
Patent DK-411887-A (DK)
Inventor: BOYER JEAN-FRANCOIS
IPC: A61K9/54
Filed: 1987-08-07
Abstract: A granular medicine based on fenofibrate, each granule comprising an inert core, a layer based on fenofibrate, and a protective layer, the medicine being characterized in that the fenofibrate in the layer based on fenofibrate is present in the form of crystalline microparticles of dimensions not greater than 30 microns, and preferably less than 10 microns.
Patent DK-416887-A (DK)
Inventor: COSTENOBLE ULLRICH
IPC: B65D85/58
Filed: 1987-08-11
Abstract: The package (1), which is impermeable to air and water vapour and is intended, in particular, for zinc/air hearing aid batteries of the button cell type, is formed partially from a tear-resistant, preferably transparent film (2) of PVC or polyvinylidene chloride with cup-shaped elevations (3) for accommodating the button cells and partially from an aluminium closure foil (5) which is sealed flatly onto said film. To remove a button cell (4), the latter needs only to be pressed from the outside through the easily tearable aluminium foil. In the case of particularly reliable packages for despatch to areas with an extremely humid or dry climate, both the cup film and the closure foil can be based on a multi-layered plastic/metal composite material. <IMAGE>
Patent DK-426788-A (DK)
Inventor: ABPLANALP ROBERT HENRY
IPC: B65D/
Filed: 1988-07-29
Abstract: An aerosol valve comprising a mounting cup (10), a gasket (14) having a central opening, a valve housing (12), a valve stem (20) and a valve body (16), wherein the valve stem and valve body move within the valve housing in response to pressure on the valve stem, the improvement comprising a valve body having at least one upstanding wall (26) defining a recess (22) in the valve body and having a slot (21) extending from the top shoulder of the upstanding wall which slot communicates with the interior of the container when the valve is actuated; a valve stem having a longitudinal opening therethrough and a member (24) that frictionally and releasably engages within the valve body recess, said valve stem further having an orifice (42) aligned with the longitudinal opening of the valve stem, which communicates at one side with the slot in the recess of the valve body and at the other side with the longitudinal opening in the valve stem; and the central opening of the gasket sealing the slot defined by the upstanding wall of the valve body when the valve is in a closed position.
Patent DK-444381-A (DK)
Inventor: LIOT R
IPC: A23B5/02
Filed: 1981-10-07
Abstract: Process for preparing a concentrated egg white or salted whole egg product capable of containing other food ingredients and flavorings and of being preserved protected from the air, according to which the initial egg white is concentrated to a dry solids content of at least 55% compared with the final egg product, in such a manner that at all times and at all points the temperature of the product being processed never exceeds 47 DEG  C.; or else the initial whole egg is concentrated to a dry solids content of at least 51% compared with the final egg product, in such a manner that at all times and at all points the temperature of the product being processed never exceeds 60 DEG  C., with an amount of between 2 and 4% by weight of added salt compared with the final egg product being added before, during or after concentration. The product obtained can be preserved at least three months at ambient temperature and a further week at 37 DEG  C. After rehydration it is used in making confectionery or for any food preparation in a similar way to that of fresh egg white or whole egg.
Patent DK-508486-A (DK)
Inventor: ABRAMS MICHAEL J
IPC: A61K33/24
Filed: 1986-10-23
Abstract: The present invention relates to radiosensitization and, more particularly, to rendering hypoxic cells more sensitive to being killed by X-rays or other forms of irradiation. In particular, the invention is directed to a pharmaceutical composition containing a radio-sensitizing amount of Co (III) or Fe (III) coordination compound selected from the group consisting of: 
 
  (1) compounds having the formula:
 [CoNnX6-n]<Y> (1)
 where n has a value of 3 or 4;
 N is an uncharged nitrogen donor atom that is contained in a ligand;
 X represents an anionic ligand; and
 Y represents the charge on the complex; 
  (2) compounds having the formula:
 (CoA2X<1>D)<Y @> (2)
 where A represents a bidentate or tetradentate negative ligand containing N or O donor atoms:
 X<1> and D represent the same or different monodentate ligands; and
 Y<1> represents a positive or negative charge on the complex; 
  (3) compounds having the formula:
 [CoZ3] (3)
 where Z represents a chelating mononegative ligand; and 
  (4) Compounds of the formula:
 [Fe TT<1>]<+> (4)
 where T and T<1>, which may be the same or different, represent mono-negative tridentate ligands. 
 
<??>The invention also includes a method for rendering hypoxic cells more sensitive to irradiation which comprises subjecting the cells to treatment using the Co (III) or Fe (III) coordination compounds defined above.
Patent DK-578286-A (DK)
Inventor: AXNER KARL YNGVE
IPC: F41J5/06
Filed: 1986-12-02
Abstract: A shooting target can have an acoustic chamber 4, in which internal microphones 5 are mounted for receiving sound waves which are produced by a projectile 6 which is fired towards the target. The internal microphones 5 are connected to equipment which is adapted to determine the impact position of the projectile on the basis of differences in the transit time of the sound waves to said microphones 5. An external microphone 9 is positioned on the front side of the target, essentially in the front plane of the target, to receive sound waves which are produced by a projectile 6 which is fired towards the target at supersonic speed. The external microphone 9 is connected to equipment which is adapted to determine the supersonic speed of the projectile on the basis of the impact position of the projectile and the transit time of the sound waves to the external microphone 9. <IMAGE>
Patent DK-640588-A (DK)
Inventor: BURKHARDT ROLF
IPC: A61B10/02
Filed: 1988-11-16
Abstract: The hollow milling cutter (9) used for cutting out a sample of cartilage or bone is screwed to the drive shaft (6) of a drive mechanism. Arranged in the hollow milling cutter (9) is a collet chuck (10), which serves as an extractor and which can be screwed forwards and backwards by means of a nut which can be screwed on the milling cutter holder (7) holding the milling cutter (9), and the opening of which collet chuck reduces during the forward screwing in order to secure the bone sample. Mounted displaceably inside this collet chuck is an ejector (15), which is connected by means of a transverse pin (16) to an ejector sleeve (17) used for activation. 
<IMAGE>
Patent DK-688088-A (DK)
Inventor: JONGH HENDRIK PAUL DE
IPC: A61K31/58
Filed: 1988-12-09
Abstract: The invention relates to new 11-arylsteroid compounds, having a strong antiprogestin and a weak or nonexistent antiglucocorticoid activity, to processes for preparing said compounds and also to pharmaceutical preparations which contain these derivatives as active constituent, characterized in that said steroids have the following formula: <CHEM>  in which  R1      is an aryl group with a - @@@X   group as substituent, X and Y each being separately H or a (1-4 C) hydrocarbyl group or together a (2-6 C) hydrocarbyl group which forms a 3- to 7-membered ring together with the nitrogen atom; R2      is hydrogen, hydroxyl, an acyloxy or an alkoxy group or a saturated or unsaturated hydrocarbyl group containing 1-8 carbon atoms, which hydrocarbyl group is provided with at least one hydroxyl, oxo, azido, cyano and/or halogen group; R3      is a hydroxyl, an acyloxy or an alkoxy group or an acyl group optionally substituted by a hydroxyl, alkoxy, acyloxy or halogen group; or R2 and R3 together form a ring system, with the proviso that if R3 is hydroxyl, R2 is not hydrogen or hydroxyl; and  R4 is a methyl or ethyl group; and the  alpha - and  beta -bonds are indicated by dashed (---) and wedged ( @) lines respectively.
Patent FI-863385-A (FI)
Inventor: LINSKY CARY BRUCE
IPC: A61B19/00
Filed: 1986-08-21
Abstract: An absorbable fabric which effectively reduces the incidence of postoperative adhesions when used as a physical barrier at the operative site is a warp knit fabric of oxidized regenerated cellulose or other bioresorbable material. The barrier fabric is particularly characterized by having a density of 8 to 15 mg/cm<sup>2</sup> and an open area porosity of 12 to 20 percent.
Patent FI-870952-A (FI)
Inventor: GIBBONS CHARLES E
IPC: B32B27/10
Filed: 1987-03-04
Abstract: The present invention relates to an improved container for citrus juices and other liquids. The container utilizes a paper­board barrier laminate (34, 36, 38, 40) for the containment of essential oils and the prevention of losses of Vitamin C. Also disclosed is a process of making the laminate. The laminate makes use of a layer of a heat-sealable glycol-modified polyethylene terephthalate (40) to enhance the barrier properties of the laminate.
Patent FI-890693-A (FI)
Inventor: PERSSON BENGT
IPC: B65D77/04
Filed: 1989-02-14
Abstract: A package comprising two joined members. One member (21) is a closed member of cardboard (21) or corresponding material and the other member (18) is flexible (18). Said one member has a closed peripheral portion and a completely covering bottom which is continuous with the peripheral portion. The flexible member is fastened along its entire periphery at at least as many points of the outer member that the package has a stable shape.
Patent FI-906352-A (FI)
Inventor: NURMINEN MATTI
IPC: C01B35/06
Filed: 1990-12-21
Abstract: The invention relates to a method for removing boron trifluoride from the exhaust gases of a vacuum pump, which gases have been obtained when polymerizing  alpha -olefines by using a BF3-alcohol complex as a catalyst. In a vacuum distillation, the underpressure is achieved by means of a pump sealed with a fluid ring or by means of fluid jet with a torque or ejector pump, possibly assisted by a mechanical booster, such as a propellant circulating pump. In this pump, the fluid ring or the fluid jet is formed by a cocatalyst forming a complex with the BF3 catalyst, which cocatalyst is an alcohol, preferably butanol.
Patent FI-925260-A (FI)
Inventor: LIU PAUL SAI-HO
IPC: A61K31/435
Filed: 1992-11-19
Abstract: Amide and ester derivatives of 6-amino-octahydro-1,7,8-indolizinetriol are described herein. The compounds are prepared from castanospermine by replacing the appropriate hydroxy function with an amino function while protecting the other hydroxy groups in the meantime. The compounds are useful as hexosaminidase inhibitors.
Patent FI-934644-A (FI)
Inventor: LORENZ HANS-PETER
IPC: E04C2/12
Filed: 1993-10-21
Abstract: The invention relates to a wall element for forming a building wall. In order to provide a wall element, which can be easily handled, and a wall which comprises a multiplicity of such wall elements, is quick to erect and provides the desired wall progression, the wall element is formed by two vertical, mutually parallel wall panels (11, 12, 31, 32) which consist of timber or derived timber products and are spaced apart by web panels (13, 14). The wall panels (11, 12, 31, 32) are provided on their topside, their bottom side and their end sides with connecting elements (15, 16) for engagement with corresponding connecting elements (15, 16) of neighbouring wall elements. The connecting elements are preferably formed by grooves (16) and tongues (15). <IMAGE>
Patent FI-954213-A (FI)
Inventor: GRINDEY GERALD BURR
IPC: A61K31/40
Filed: 1995-09-08
Abstract: This invention provides certain indolinesulfonamide and substituted-indolesulfonamide derivatives of the formula <CHEM>  wherein: <CHEM>  R<1> is C1-C6 alkyl; R<2> and R<3> are independently selected from the group consisting of hydrogen, halo, C1-C6 alkyl, and trifluoromethyl, provided that no more than one of R<2> and R<3> can be hydrogen; and methods for using them in the treatment of susceptible neoplasms in mammals. Also provided are certain novel pharmaceutical formulations employing these indolinesulfonamide and substituted-indolesulfonamide derivatives in combination with a carrier, excipient or diluent, as well as processes for preparing the compounds.
Patent FI-960207-A (FI)
Inventor: ROWAN THOMAS J
IPC: A47B1/03
Filed: 1996-01-16
Abstract: A convertible table for forming an expanded table surface area. The convertible table is comprised of overlying and underlying table members which are connected by a pivot pin. The underlying table member is capable of sliding along a member connected to the table support to center the weight of the expanded table after rotation of the overlying table member. The construction of the converting mechanism permits the overlying and underlying table members to be formed in a variety of shapes.
Patent FI-961013-A (FI)
Inventor: BOODE-BOISSEVAIN KARIN
IPC: A21D13/00
Filed: 1996-03-05
Abstract: Laminated dough systems, comprising alternating layers of dough and laminated fat, which laminated fat layers contain a water-binding agent, while simultaneously at least one of the outer layers of the system is provided with a moisture barrier layer display improved properties like crispness, when subjected to microwaves.
Patent FI-963550-A (FI)
Inventor: HEINZEL GUNTER
IPC: C02F1/52
Filed: 1996-09-10
Abstract: Prepn. of a solid composite prod. (A) for water treatment comprises reacting zeolite-contg. powdered stone (B) and polyaluminium chloride (I), opt. partially hydrolysed, with heating.
Patent FI-972455-A (FI)
Inventor: SAIRANEN MARTTI
IPC: H03K17/082
Filed: 1997-06-10
Abstract: PCT No. PCT/FI98/00495 Sec. 371 Date Mar. 31, 1999 Sec. 102(e) Date Mar. 31, 1999 PCT Filed Jun. 9, 1998 PCT Pub. No. WO98/59421 PCT Pub. Date Dec. 30, 1998A power control (20, 40) for controlling the electric power fed from voltage source (12) to a load (13) comprises a field effect transistor (21, Q1) for either allowing or disabling the flow of current from voltage source to load as a response to the presence or absence of a control pulse led to the gate of the field effect transistor. Additionally the power control comprises means for measuring the change of the gate potential of the field effect transistor (24, R6, R7) and for either allowing or disabling a control pulse on the basis of the gate potential change measurement. In the power control the control pulse is allowed to switch the field effect transistor (21, Q1) to conducting state when a stop (31) in the voltage increase due to Miller effect is detected at the start of the control pulse, and the control pulse is respectively disabled from switching the field effect transistor to conducting state when no Miller effect stop (33) is detected in the field effect transistor gate potential change at the start of the control pulse.
Patent FR-1559271-A (FR)
IPC: G04B17/20
Filed: 1968-03-07
Granted: 1969-03-07
Abstract: 1,163,706. Electric timepieces. CENTRE ELECTRONIQUE HORLOGER S.A. March 1, 1968 [March 31, 1967], No.10041/68. Heading G3T. A mechanical resonator for a timepiece comprises two branches 1, 2 adapted to oscillate in phase opposition, each having at its free end a mass 5, 6 belonging to a transducer maintaining the vibrations of the resonator and each branch having a flexible part 12, 13 to allow displacement of the masses under the influence of gravity in order to reduce the charge in frequency of the resonator due to its change in orientation. The masses oscillate in the direction of the line 11 but are displaced in a direction having a component perpendicular to the line 11 depending on the orientation of the resonator. Members 7, 8 are provided for fine adjustment of the frequency of oscillation of the resonator. In a modification the resonator comprises two parallel straight arms each having at its free end an inwardly facing U-shaped arm positioned at right angles to the straight arms. The flexible part is provided by the curved portion of each U-shaped arm to the free ends of which the masses are secured.
Patent FR-1605257-A (FR)
Title: Solid propergols contg a polydiolefin binder - with carboxylic acid groups and polyaziridinyls or polyepoxides as crosslinking agents
IPC: C08L13/00
Filed: 1962-04-06
Granted: 1973-11-30
Abstract: 55-10% of binder is mixed with 45-90% oxidising (reducing) fillers, where the binder contains at least two COOH's per mol. reacted with a cpd. contg. at least two functional groups/mol. such as aza(cyclo) bis carbane where the polydiolefin (I) (a) is prepd. by copolymerisation of alpha-diolefin such as butadiene or isoprene with a mono-olefin contg. COOH groups such as (meth) acrylic acid or (b) (I) has a terminal COOH at each end and is obtd. by polymerising a diolefin with an organo bis alkaline cpd. and treating the product with CO2 and then acid to initiate polymerisation with azoic catalyst contg. COOH groups such as aza-4,4' bis-4 pentanoic acid. (I) has acid equiv. 0.2-2/kg and mol. wt. 500-10,000. Crosslinking agents are present in amount 0.7-3 in proportion to (I). The mixt. at 20-120 degrees C is cured in moulds at 20-120 degrees C for 2-15 days. The product has good mechanical strength and low shrinkage.
Patent GB-1003266-A (GB)
Title: Molecular sieve formed bodies hardened with a binding agent
IPC: B01J20/18
Filed: 1963-01-09
Abstract: Formed synthetic crystalline zeolite bodies are hardened with a binding agent comprising an oxide, hydroxide, or basic salt of an alkaline earth metal.  The bodies may be formed by mixing a synthetic crystalline zeolite powder with one of (a) an aqueous dispersion of an alkaline earth metal oxide or hydroxide, (b) an aqueous solution of an alkaline earth metal salt mixed with an alkali metal hydroxide, (c) a slurry of an alkaline earth metal oxide or hydroxide mixed with an acid, or (d) an aqueous mixture of an alkaline earth metal oxide or hydroxide and an alkaline earth metal salt. The binding agent may comprise from 5% to 40% by weight of the solid formed body, and the synthetic crystalline zeolite powder may comprise from 20% to 30% by weight of the said body.  The mixture may be dried, preferably in a mould, at a temperature of up to 400 DEG  C.  The formed bodies may be reacted with calcium chloride solution, washed with water, dried at 150-200 DEG  C. followed by dehydration at 300-350 DEG  C. under reduced pressure.ALSO:Formed synthetic crystalline zeolite bodies are hardened with a binding agent comprising an oxide, hydroxide, or basic salt of an alkaline earth metal.  The bodies may be formed by mixing a synthetic crystalline zeolite powder with either (a) an aqueous dispersion of an alkaline earth metal oxide or hydroxide, (b) an aqueous solution of an alkaline earth metal salt mixed with an alkali metal hydroxide, (c) a slurry of an alkaline earth metal oxide or hydroxide mixed with an acid, or (d) an aqueous mixture of an alkaline earth metal oxide or hydroxide and an alkaline earth metal salt.  The mixture may be dried at up to 400  DEG C.  The formed bodies may be reacted with calcium chloride solution, washed with water, dried at 150-200  DEG C. and dehydrated at 300-350  DEG C. under reduced pressure.  They may be used for separation of straight chain paraffins from hydrocarbon mixtures.